Applications published 21 October 2009

Process for the preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
AstraZeneca 2109443*

Bone growth particles and osteoinductive compsn thereof
Zimmer Orthobiologics 2109444*

Compsns for topical application comprising a peroxide and retinoid
Sol-Gel Technologies 2109445*

Absorbable solid compsns for the topical treatment of oral mucosal disorders
Axiomedic 2109446*

N, N"-dimethyl imidocarbonimidic diamide acetate, method for producing the same, and pharmaceutical compsns comprising the same
Hanell Pharmaceutical 2109447*

Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydrocamptothecin
Enzon Pharmaceuticals 2109448*

Medicament for the treatment of endometriosis
Ferring International Center 2109449*

Method of neuroprotection by cyclin-dependent kinase inhibition
Panacea Pharmaceuticals 2109450*

Encapsulated picoplatin
Poniard Pharmaceuticals 2109451*

Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumour treatment
Hemholtz-Zentrum fuer Infektionsforschung 2109452*

Angioinhibin
Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum 2109453*

GLP-1 pharmaceutical compsns
Ipsen Pharma 2109454*

Compsns and methods for stimulating an immune response
The Johns Hopkins University 2109455*

Human EPO receptor agonists, compsns, methods and uses for preventing or treating glucose intolerance related conditions
Centocor Ortho Biotech 2109456*

• Therapeutic application of kazal-type serine protease inhibitors
CSL Behring 2109457*

• Sugar immunogens
United Therapeutics 2109458*

• Archaeal polar lipid aggregates for administration to animals
National Research Council of Canada 2109459*

• Anti-kir antibodies, formulations, and uses thereof
Novo Nordisk 2109460*

• Method for improving pharmacokinetics
Ambrillia Biopharm 2109461*

• Antitumour combination comprising a morpholinyl anthracycline and an antibody
Nerviano Medical Services 2109462*

• Multimeric conjugate
Scil Proteins 2109463*

• Polymers of aliphatic thioester
Abbott Cardiovascular Systems 2109464*

• Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
Kempharm 2109465*

• Positron emission tomography imaging method
Purdue Research Foundation 2109466*

• Amorphous and crystalline forms of rivastigmine hydrogentartrate
Krka Tovarna Zdravil 2109600*

• Preparation of darifenacin and its salts
Dr Reddy's Laboratories 2109601*

• Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
Paratek Pharmaceuticals 2109602*

• Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1H)-quinolinone monohydrochloride
Chiesi Farmaceutici 2109603*

• 6-oxo-6,7-dihydro-5H-dibenzo[B,D]azepin-7-yl derivatives
F Hoffmann-La Roche 2109604*

• 2-[(phenylamino_=pyrimidin-4ylamino]-cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
Boehringer Ingelheim International 2109605*

• ChromeneS 1P1 receptor antagonist
Novartis 2109606*

• Pyrrolo(3,2-A)pyridine derivatives for inhibiting KSP kinesin activity
Schering 2109607*

• Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
Istituto di Richerche di Biologia Molcolare P Angeletti 2109608*

• Novel quinuclidine derivative useful in the preparation of mequitazine
Pierre Fabre Medicament 2109609*

• 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-C]quinoline compounds useful as PDE5 inhibitors
Nycomed 2109610*

• 7-azaindole derivatives and their use in the inhibition of C-jun N-terminal kinase
Eisai R&D Management 2109611*

• 5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
AstraZeneca 2109612*

• Polymorphs of eszopiclone malate
Teva Pharmaceutical Industries 2109613*

• Enantioselective synthesis of 6-amino-7-hydroxy-[4,5,1-JK][1]-benzazepin-2-[1H]-one and zilpaterol
Intervet International 2109614*

• Substituted pyrano [2,30B]pyridine derivatives as cannabinoid-1 receptor modulators
Merck 2109615*

• Method for lithium exchange reactions
Lonza 2109616*

• Nitric oxide releasing steroids
Nicox 2109617*

• Nitric oxide releasing steroids
Nicox 2109618*

• Modifications of peptide compsns to increase stability and delivery efficiency
Kai Pharmaceuticals 2109619*

• Interleukin-21 variants with altered binding to the IL-21 receptor
Novo Nordisk 2109620*

• Factor H polymorphs in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
University College Cardiff Consultants 2109621*

• High affinity antibodies that neutralise staphylococcus enterotoxin B
Morphotek 2109622*

• Treatment of cancer with anti-IL-1 antibodies
Xbiotech 2109623*

• Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body specific to human hepcidin and associated uses therefor
DRG International 2109624*

• Use of antibody conjugates
The Regents of the University of California; The Government of the United States as represented by the Department of Veterans Affairs 2109625*

• Process for preparing cellulose ether
Akzo Nobel 2109626*

• Apparatus for high throughput chemical reactions
Wafergen 2109627*

• Method for producing water-absorbing polymer particles by suspension polymerisation
BASF SE 2109628*

• Microfluidic and anaofluidic devices, systems and applications
Microchip Biotechnologies 2109666*

• Extracellular matrix cancer vaccine adjuvant
University of Notre Dame 2109667*

• Human cancer stem cells
Raven Biotechnologies 2109668*

• Methods for reversibly binding a biotin compound to a support
Invitrogen 2109669*

• Production of a lipid acyltransferase from transformed bacillus licheniformis cells
Danisco 2109670*

• Expression cassette, vector, host cell, a method for producing a polypeptide
Instytut Biotechnologii I Antybiotykow 2109671*

• DNA sequence encoding penicillin acylase, novel recombinant DNA constructs and recombinant microorganisms carrying this sequence
Fermenta Biotech; Mikrobiologicky 2109672*

• Methods and compsns for enhanced protein expression and purification
Lifesensors 2109673*

• High expression cell line that eliminates gene amplification
Millipore 2109674*

• New microorganisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design
Metabolic Explorer 2109681*

• Enhanced cell-free synthesis of active proteins containing disulphide bonds
The Board of Trustees of the Leland Stanford Junior University 2109682*

• Detection of chiral alcohols and other analytes
University of Durham 2109683*

• Method of detecting pathogenic legionella strains
Mederlandse Organisatie Voor Natuurwetenschappelijk Onderzoek 2109684*

• Systems and methods for polymer characterisation
International Business Machines 2109685*

• Genetic markers for predicting responsiveness to combination therapy
University of Southern California 2109686*

• Micro-RNA-based methods and compsns for the treatment of acute myeloid leukaemia
The Ohio State University Research Foundation 2109687*

• Galectin-3-binding protein as a biomarker of cardiovascular disease
University of Virgina Patent Foundation 2109688*

• Detection of tissue proximity
Perscitus Biosciences 2109689*

• Movel tissue protective erythropoietin receptor (NEPOR) and methods of use
Alepor 2109690*